15 Results for "

CL2 Linker

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "CL2 Linker" in MCE Product Catalog:

11
11 Publications Verification
製品番号: HY-132254
CAS 番号: 1491917-83-9
純度:  99.13%
別名: IMMU-132
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. The antibody portion is Sacituzumab (HY-P99045), and the drug-linker conjugate for ADC is CL2A-SN-38 (HY-128946). Sacituzumab govitecan shows anticancer activity .
loading...
    loading...
11
11 Publications Verification
製品番号: HY-132254A
CAS 番号: 1491917-83-9
純度:  96.61%
別名: IMMU-132 (solution)
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. The antibody portion is Sacituzumab (HY-P99045), and the drug-linker conjugate for ADC is CL2A-SN-38 (HY-128946). Sacituzumab govitecan shows anticancer activity .
loading...
    loading...
7
7 Cited Publications
製品番号: HY-128946
CAS 番号: 1279680-68-0
純度:  99.07%
CL2A-SN-38 is a agent-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody agent conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A-SN-38 uses hydrolyzable linker to deliver active agents within tumor cells and in the tumor microenvironment, resulting in bystander effects .
loading...
    loading...
1
1 Cited Publications
製品番号: HY-126350
CAS 番号: 1036969-20-6
純度:  99.14%
研究分野:  

Cancer

CL2-SN-38 is a cleavable linker-based agent-Linker conjugate, it can conjugate with the anti-Trop-2-humanized antibody hRS7. CL2-SN-38 can be used for the reasearch of cancer .
loading...
    loading...
製品番号: HY-128945
CAS 番号: 2616704-22-2
純度:  99.49%
Target:  

ADC Linkers

研究分野:  

Inflammation/Immunology Cancer

CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker .
loading...
    loading...
製品番号: HY-128947
CAS 番号: 2270986-66-6
Target:  

ADC Linkers

研究分野:  

Cancer

CL2 Linker is a cleavableADC linker. CL2-SN-38 and CL2A-SN-38 are equivalent in agent substitution (~6), cell binding (Kd ~1.2 nM), cytotoxicity (IC50 ~2.2 nM), and serum stability in vitro (t1/2 ~20 hours) .
loading...
    loading...
製品番号: HY-164668
研究分野:  

Cancer

ADC Control Human IgG1-SN-38 is an isotype control of ADC Human IgG1-SN-38. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is CL2A-SN-38 (HY-128946).
loading...
    loading...
製品番号: HY-170868
CAS 番号: 3025194-00-4
研究分野:  

Cancer

CL2A-FL118 is a drug-linker for synthesis of ADC molecule Sac-CL2A-FL118 .
loading...
    loading...
製品番号: HY-129622A
CAS 番号: 2241669-16-7
純度:  ≥98.0%
Target:  

PROTAC Linkers

研究分野:  

Cancer

NH2-PEG5-C6-Cl hydrochloride is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
loading...
    loading...
製品番号: HY-129622
CAS 番号: 1261238-22-5
Target:  

PROTAC Linkers

研究分野:  

Cancer

NH2-PEG5-C6-Cl (K-7) is a linker which refers to the PEG composition. NH2-PEG5-C6-Cl can be used in the synthesis of a series of compounds that induce degradation of intracellular molecules by autophagy .
loading...
    loading...
製品番号: HY-160825
CAS 番号: 1846605-04-6
Target:  

ADC Linkers

研究分野:  

Cancer

CL2A acid is a ADC linker for synthesis of Antibody-drug conjugates (ADCs)
loading...
    loading...
製品番号: HY-128945A
Target:  

ADC Linkers

研究分野:  

Inflammation/Immunology Cancer

CL2A TFA is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A TFA is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker .
loading...
    loading...
製品番号: HY-W096116
CAS 番号: 78925-46-9
Target:  

PROTAC Linkers

研究分野:  

Cancer

PEG2-Cl is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
loading...
    loading...
製品番号: HY-138469
CAS 番号: 1261350-60-0
純度:  ≥95.0%
Target:  

PROTAC Linkers

研究分野:  

Cancer

NH2-PEG3-C6-Cl is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
loading...
    loading...
製品番号: HY-181679
Target:  

ADC Linkers

研究分野:  

Cancer

TML-2Cl is a dichloro-modified trimethyl lock adapter for antibody-drug conjugates and payload releaser.TML-2Cl undergoes 1,6-elimination followed by rapid self-cyclization to facilitate release of the payload Exatecan after cathepsin B cleavage of the associated linker.TML-2Cl exhibits high stability when conjugated to a drug and high intrinsic hydrophobicity.TML-2Cl can be used for the research of gastric carcinoma .
loading...
    loading...
  • 1